BioMall
Brand Store/BDB Bioscience/BD PharmingenTM FITC Annexin V Apoptosis Detection Kit I
BD PharmingenTM FITC Annexin V Apoptosis Detection Kit I
GENERAL CATALOGUE

BD PharmingenTM FITC Annexin V Apoptosis Detection Kit I

556547 ·

BDB Bioscience · Cat: 556547

₹230 – ₹340 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 556547
Category: reagents
Brand: BDB Bioscience

Description

Flow Cytometric Analysis of FITC Annexin V staining. Jurkat cells Human T-cell leukemia; ATCC TIB-152 were left untreated top panels or treated for 4 hours with 12 muM campotothecin bottom panels . Cells were incubated with FITC Annexin V in a buffer containing propidium iodide PI and analyzed by flow cytometry. Untreated cells were primarily FITC Annexin V and PI negative, indicating that they were viable and not undergoing apoptosis. After a 4 hour treatment bottom panels , there were primarily two populations of cells: Cells that were viable and not undergoing apoptosis FITC Annexin V and PI negative and cells undergoing apoptosis FITC Annexin V positive and PI negative . A minor population of cells were observed to be FITC Annexin V and PI positive, indicating that they were in end stage apoptosis or already dead. Flow Cytometric Analysis of FITC Annexin V staining. Jurkat cells Human T-cell leukemia; ATCC TIB-152 were left untreated top panels or treated for 4 hours with 12 muM campotothecin bottom panels . Cells were incubated with FITC Annexin V in a buffer containing propidium iodide PI and analyzed by flow cytometry. Untreated cells were primarily FITC Annexin V and PI negative, indicating that they were viable and not undergoing apoptosis. After a 4 hour treatment bottom panels , there were primarily two populations of cells: Cells that were viable and not undergoing apoptosis FITC Annexin V and PI negative and cells undergoing apoptosis FITC Annexin V positive and PI negative . A minor population of cells were observed to be FITC Annexin V and PI positive, indicating that they were in end stage apoptosis or already dead. Show More Flow Cytometric Analysis of FITC Annexin V staining. Jurkat cells Human T-cell leukemia; ATCC TIB-152 were left untreated top panels or treated for 4 hours with 12 muM campotothecin bottom panels . Cells were incubated with FITC Annexin V in a buffer containing propidium iodide PI and analyzed by flow cytometry. Untreated cells were primarily FITC Annexin V and PI negative, indicating that they were viable and not undergoing apoptosis. After a 4 hour treatment bottom panels , there were primarily two populations of cells: Cells that were viable and not undergoing apoptosis FITC Annexin V and PI negative and cells undergoing apoptosis FITC Annexin V positive and PI negative . A minor population of cells were observed to be FITC Annexin V and PI positive, indicating that they were in end stage apoptosis or already dead.

More from BDB Bioscience

BD HorizonTM BV421 Mouse Anti-Human TIGIT
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents